Search filters

List of works by Tsung-Hui Hu

A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir

scientific article published on 12 June 2018

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study.

scientific article

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.

scientific article published on 28 June 2018

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery

scientific article published on 29 April 2020

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

scientific article published on 03 October 2019

Clinical and novel application of FibroScan, FIB-4, and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in esophageal variceal prediction

scientific article published on 18 December 2020

East Asia expert opinion on treatment initiation for chronic hepatitis B

scientific article published on 20 September 2020

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

scientific article published on 01 June 2020

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

scientific article published on 02 December 2019

Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience

scientific article published on 07 October 2019

Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan

scientific article published on 27 October 2020

Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantation

scientific article published on 18 July 2018

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

scientific article published on 28 November 2018

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.

scientific article

Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West

scientific article published on 12 March 2020

Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis

scientific article published on 08 May 2019

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

scientific article published in PLoS ONE

The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.

scientific article

The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients.

scientific article published on 23 December 2017

Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study

scientific article

Paulina is supported by:

About Paulina

Help